News

WuXi AppTec Earns 2024 EcoVadis Silver Medal for Sustainability

WuXi AppTec Earns 2024 EcoVadis Silver Medal for Sustainability

WuXi AppTec Achieves EcoVadis 2024 Silver Medal Recognition

WuXi AppTec, a global leader providing R&D and manufacturing services, has achieved significant recognition with its Couvet facility receiving the silver medal from EcoVadis in their 2024 business sustainability ratings. This commendation attests to WuXi AppTec's unwavering dedication to integrating Environmental, Social, and Governance (ESG) priorities into its corporate strategy.

Understanding EcoVadis Ratings and Their Importance

EcoVadis is a prominent provider of sustainability ratings, helping businesses enhance their social and environmental responsibilities across the globe. By evaluating corporate performance in critical areas such as Environment, Labor & Human Rights, Ethics, and Sustainable Procurement, EcoVadis helps to set benchmarks for improvement. WuXi AppTec's Couvet site earned a remarkable score, placing it among the top 9% of all rated companies, which reaffirms its commitment to responsible and sustainable business practices.

Features of the Couvet Facility

The Couvet site stands out as a state-of-the-art pharmaceutical manufacturing facility, central to WuXi AppTec's Comprehensive Drug Research and Development Model Organization (CRDMO). It plays a crucial role in providing clinical and commercial-scale manufacturing capabilities for oral solid dosage forms. Notably, the facility is constructed with cutting-edge energy efficiency and adheres to high environmental standards, paving the way for sustainable growth in the pharmaceutical industry.

Recognition Beyond EcoVadis

In addition to the EcoVadis silver medal, the Couvet site has maintained its certifications of ISO 14001 & ISO 45001, which validate its commitment to advanced environmental and safety management systems. These accolades are a testament to WuXi AppTec's efforts to improve sustainability within its operations.

WuXi AppTec's Global Sustainability Initiatives

As a proactive force in the pharmaceutical and life sciences sectors, WuXi AppTec integrates ESG considerations into its global operations. In 2024, it attained the top rank in the Global Life Sciences Tools & Services Industry within the S&P Global Corporate Sustainability Assessment, while also achieving an AA ESG rating from MSCI for the fourth consecutive year. The company's impressive performance has also seen it listed in the S&P Global Sustainability Yearbook and the FTSE4Good Index Series annually.

Collaboration for a Sustainable Future

WuXi AppTec's commitment to sustainability extends beyond its internal practices. The company joined the United Nations Global Compact (UNGC) to uphold ten essential sustainability principles and became part of the Science Based Targets initiative in 2023, aimed at reducing carbon emissions.

About WuXi AppTec

WuXi AppTec distinguishes itself as a global entity with operations in Asia, Europe, and North America. It offers a comprehensive portfolio of R&D and manufacturing solutions, designed to empower the worldwide pharmaceutical and life sciences industries to enhance their discoveries and deliver innovative treatments to patients. The company's integrated services encompass chemistry drug CRDMO, biology discovery, and advanced therapies CTDMO, enabling customer efficiency and innovation in advancing healthcare.

Frequently Asked Questions

What does the EcoVadis silver medal signify for WuXi AppTec?

The EcoVadis silver medal signifies WuXi AppTec's strong commitment to sustainability and ethical business practices, ranking in the top 9% of evaluated companies.

What are the main areas assessed by EcoVadis?

EcoVadis assesses companies based on Environment, Labor & Human Rights, Ethics, and Sustainable Procurement to measure sustainability performance.

What role does the Couvet site play within WuXi AppTec?

The Couvet site is critical for WuXi AppTec's pharmaceutical manufacturing, providing clinical and commercial-scale capabilities for oral solid dosage forms.

What other certifications has the Couvet facility achieved?

In addition to the EcoVadis recognition, the Couvet facility holds ISO 14001 & ISO 45001 certifications, demonstrating its commitment to environmental and health standards.

How does WuXi AppTec support global sustainability?

WuXi AppTec supports global sustainability by incorporating ESG priorities in its operations and joining initiatives like the UN Global Compact and Science Based Targets initiative.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 356

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 371

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 150

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 347

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 204

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 309

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 238

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 177

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 433

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 243

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading

Top 5 Most Recently Viewed Articles

Cryptocurrency Market Analysis: Bitcoin Hits New Low

Updated Category News Views 197

Cryptocurrency Market Update On Friday morning, cryptocurrency enthusiasts awoke to disappointing news: Bitcoin has fallen below $109,000, marking a significant decline for the leading digital asset. This marks the first time Bitcoin has dipped below this level since early September, raising questions about the current state and future of digital currencies. Key...

Continue Reading
Hagar hf. Expands Operations with P/F SMS Acquisition

Updated Category News Views 239

Hagar hf. Expands Its Business Footprint Recently, a significant announcement was made about Hagar hf. enhancing its business strategy through the acquisition of P/F SMS, a prominent supermarket chain in the Faroe Islands. This strategic move was publicized on a notable occasion, indicating the completion of a conditional agreement that allows Hagar hf. to fully acquire...

Continue Reading
Santander Achieves Impressive 12% Net Profit Growth in Q3

Updated Category News Views 238

Santander's Robust Net Profit Growth in Q3 Spain's Santander has announced an impressive 12% increase in net profit for the third quarter of 2023, underscoring the effectiveness of its retail operations. This remarkable performance has positioned the bank as one of the strongest contenders in the euro zone banking sector. Financial Highlights for Q3 In the latest...

Continue Reading
DBM Global Secures $220 Million Credit Facility for Growth

Updated Category News Views 318

DBM Global Inc. Enters Amended Credit Facility Agreement DBM Global Inc. (OTC Markets: DBMG) has recently made headlines by securing an amended and restated credit agreement that amounts to a significant total of $220 million. This financial maneuver comprises an $85 million term loan alongside a $135 million revolving credit facility, which aims to address existing debt...

Continue Reading
Projected Growth of Industrial Safety Market to USD 12.39 Billion

Updated Category News Views 82

Overview of the Industrial Safety Market Growth The Industrial Safety Market is experiencing remarkable growth, expected to expand from USD 6.74 billion in 2023 to a substantial USD 12.39 billion by 2032. This notable surge is attributed to a compound annual growth rate (CAGR) of 7%, reflecting an increased emphasis on safety within various industrial sectors. Key Factors...

Continue Reading